Review article · 30 Nov 2023
EditorialPublished 29 Nov 2024
T Cell Lymphotropic Virus: An Overview
Department of neurology, Binghamton University, United States
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
T Cell Lymphotropic Virus (HTLV), particularly Human T-lymphotropic virus types I and II (HTLV-I and HTLV-II), is a retrovirus associated with significant hematological disorders, most notably adult T-cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). HTLV-I was first identified in the early 1980s and has since been linked to various diseases, affecting millions globally, with a prevalence concentrated in specific geographic regions such as Japan, the Caribbean, and parts of Africa.Transmission of HTLV occurs primarily through three routes: vertical transmission from mother to child during childbirth or breastfeeding, sexual contact, and parenteral exposure via contaminated needles, particularly among intravenous drug users. The virus predominantly infects CD4+ T lymphocytes, leading to their proliferation and transformation due to the viral protein Tax, which disrupts normal cellular processes. This can result in severe clinical manifestations, including ATLL, characterized by lymphadenopathy, skin lesions, and systemic symptoms, as well as TSP/HAM, a progressive neurological condition causing weakness and spasticity. Diagnosis of HTLV infection typically involves serological testing to detect antibodies against the virus, with methods such as enzyme-linked immunosorbent assay (ELISA) and Western blot analysis being the most common. Polymerase chain reaction (PCR) testing may also be utilized for definitive diagnosis. While no cure currently exists for HTLV infection, treatment strategies focus on managing associated conditions, with chemotherapy and stem cell transplantation for ATLL and supportive care for TSP/HAM.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2014
High-Frequency Oscillation and Recovery Functions of Somatosensory Evoked Potentials in Human T-Cell Lymphotropic Virus Type 1- Associated Myelopathy
Research article · 30 Jun 2019
Detection of human T-cell lymphotropic virus Type 1 among patients with malignant hematological diseases in Capital of Iran, Tehran
Research article · 3 May 2019
Polyneuropathy in patient with human T-cell lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis (HAM-TSP) and HTLV-1 carriers
Conference abstract · 10 Oct 2016
Human T cell lymphotropic virus type I (HTLV-I) associated infective dermatitis (IDH) does not associate with atopic dermatitis (AD)
More from this journal
The newest in Journal of Neuroinfectious Diseases.
Commentary · 2 Dec 2025
Molecular Diagnostics Revolutionize Neuroinfectious Disease Management
Commentary · 1 Dec 2025
Central Nervous System Opportunistic Infections: Diagnosis and Management
Opinion · 1 Dec 2025
Cerebrospinal Fluid Biomarkers For Neurological Disease Diagnosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Neuroinfectious Diseases
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Matthew S. Lebowitz”
